HEPARIN LOCK FLUSH
LOE ApproachingNDAINJECTIONINJECTABLEPriority Review
Approved
May 1974
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 2d ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Heparin Lock Flush is an injectable anticoagulant solution used to maintain the patency of intravenous lines and catheters by preventing blood clot formation. It works by inhibiting thrombin and other clotting factors through its anticoagulant mechanism. This product is essential in hospital and clinical settings to preserve vascular access.
LOE Approaching
As an aging, non-exclusive product approaching loss of exclusivity with moderate competitive pressure (30), this brand faces headwinds and limited team expansion opportunities.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Heparin Lock Flush offers limited career growth due to its mature, commoditized status and approaching loss of exclusivity. Roles focus on operational efficiency, cost optimization, and stakeholder management rather than brand-building or innovation.
Supply Chain ManagerReimbursement Specialist
Worked on HEPARIN LOCK FLUSH at Hikma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.